482 related articles for article (PubMed ID: 6187845)
21. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.
Chiba K; Nishimura T; Hashimoto Y
J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017
[TBL] [Abstract][Full Text] [Related]
22. Enumeration of IL 2-secreting helper T cells by limiting dilution analysis, and demonstration of unexpectedly high levels of IL 2 production per responding cell.
Miller RA; Stutman O
J Immunol; 1982 May; 128(5):2258-64. PubMed ID: 6977590
[TBL] [Abstract][Full Text] [Related]
23. Interactions of small B lymphocytes with unprimed noncytolytic T cells: dissociation between "presentation" and growth induction.
Bandeira A; Pereira P; Martinez C; Coutinho A
Eur J Immunol; 1985 Sep; 15(9):865-72. PubMed ID: 3876222
[TBL] [Abstract][Full Text] [Related]
24. The growth of concanavalin-A activated, Lyt selected subsets in IL-2 containing supernatants.
Kuppers RC; Simon MM; Eichmann K
Immunobiology; 1984 Oct; 167(4):365-75. PubMed ID: 6334647
[TBL] [Abstract][Full Text] [Related]
25. The functional association of Lyt antigens with lymphokine production.
Hollander N; Shepshalovich J
Immunology; 1985 Jan; 54(1):25-33. PubMed ID: 2579021
[TBL] [Abstract][Full Text] [Related]
26. Frequency analysis of class I MHC-reactive Lyt-2+ and class II MHC-reactive L3T4+ IL 2-secreting T lymphocytes.
Heeg K; Steeg C; Schmitt J; Wagner H
J Immunol; 1987 Jun; 138(12):4121-7. PubMed ID: 3108383
[TBL] [Abstract][Full Text] [Related]
27. TRF requirements for in vitro PFC responses to SRBC and R36a. I. TRF is distinct from IL 2 but indistinguishable from polyclonal BCSF.
Eisenberg L; Prystowsky MB; Dick RF; Sosman JA; Fitch FW; Quintáns J
J Immunol; 1984 Mar; 132(3):1305-10. PubMed ID: 6363538
[TBL] [Abstract][Full Text] [Related]
28. T cells produce TRF in response to Con A and factors in T cell hybridoma supernatants.
Raulet DH; Hünig T; Parker DC
J Immunol; 1982 Feb; 128(2):908-12. PubMed ID: 6798126
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of lymphokine production by murine T-lymphocyte clones.
MacDonald HR; Glasebrook AL; Kelso A; Zubler RH
Ann Immunol (Paris); 1982; 133D(2):171-8. PubMed ID: 6819809
[TBL] [Abstract][Full Text] [Related]
30. Precursor frequency analysis of lymphokine-secreting alloreactive T lymphocytes. Dissociation of subsets producing interleukin 2, macrophage-activating factor, and granulocyte-macrophage colony-stimulating factor on the basis of Lyt-2 phenotype.
Kelso A; Macdonald HR
J Exp Med; 1982 Nov; 156(5):1366-79. PubMed ID: 6752327
[TBL] [Abstract][Full Text] [Related]
31. Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic response.
Yang SS; Malek TR; Hargrove ME; Ting CC
J Immunol; 1985 Jun; 134(6):3912-9. PubMed ID: 3921614
[TBL] [Abstract][Full Text] [Related]
32. Production of lymphokines by murine cortisone resistant thymocytes stimulated by concanavalin A. III. Effect of cytotoxic pretreatment with anti-Lyt antibodies on interleukin-2 and interferon producing cells.
Pajtasz E; Kuśnierczyk P; Albin M; Kisielow P
Arch Immunol Ther Exp (Warsz); 1986; 34(4):403-7. PubMed ID: 2432850
[TBL] [Abstract][Full Text] [Related]
33. Clonal heterogeneity in colony stimulating factor production by murine T lymphocytes.
Kelso A; Metcalf D
J Cell Physiol; 1985 Apr; 123(1):101-10. PubMed ID: 3156138
[TBL] [Abstract][Full Text] [Related]
34. Postnatal development of functional T cell subsets in the mouse: a frequency analysis of mitogen reactive precursors of proliferating, of cytotoxic and of IL 2 producing T cells.
Däubener W; von Steldern D; Maxeiner B; Scheurich P; Pfizenmaier K
Immunobiology; 1985 Jul; 169(5):472-85. PubMed ID: 2864311
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoid inhibition of lymphokine secretion by alloreactive T lymphocyte clones.
Kelso A; Munck A
J Immunol; 1984 Aug; 133(2):784-91. PubMed ID: 6203981
[TBL] [Abstract][Full Text] [Related]
36. Purification of murine helper T cell-replacing factors.
Watson J; Mochizuki D; Gillis S
Prog Clin Biol Res; 1981; 66 Pt A():513-22. PubMed ID: 6975944
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of immature (Lyt-2-/L3T4-) thymocytes. Identification of four major phenotypically distinct subsets differing in cell cycle status and in vitro activation requirements.
Howe RC; MacDonald HR
J Immunol; 1988 Feb; 140(4):1047-55. PubMed ID: 3257768
[TBL] [Abstract][Full Text] [Related]
38. T cell replacing factor for steroids (TRF-S): a 40,000 dalton protein produced by a T4+ T cell.
Orson FM; Flagge FP; Cashaw JL
J Immunol; 1986 Jul; 137(2):578-84. PubMed ID: 3088104
[TBL] [Abstract][Full Text] [Related]
39. The cellular basis for immune interferon production in autoimmune MRL-Ipr/Ipr mice.
Santoro TJ; Benjamin WR; Oppenheim JJ; Steinberg AD
J Immunol; 1983 Jul; 131(1):265-8. PubMed ID: 6408174
[TBL] [Abstract][Full Text] [Related]
40. Activation of cytotoxic T lymphocytes requires at least two spleen cell-derived helper factors besides interleukin 2.
Falk W; Männel DN; Dröge W
J Immunol; 1983 May; 130(5):2214-8. PubMed ID: 6220085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
